Octreotide versus oral dietary modification for the treatment of chylous fistula following neck dissection: A systematic review and meta-analysis
- PMID: 33342047
- DOI: 10.1111/coa.13700
Octreotide versus oral dietary modification for the treatment of chylous fistula following neck dissection: A systematic review and meta-analysis
Abstract
Aims: Chylous fistula following neck surgery is a rare, but significant complication. Currently, there is no standardised treatment, which may comprise pressure dressings, oral dietary modification (ODM), surgery or a combination of such measures. Octreotide is a somatostatin analogue that has gained popularity in the management of cervical chyle leaks. The effectiveness of octreotide compared with ODM is unclear. We provide a comprehensive, systematic review of the literature pertaining to the management of chylous fistulae, comparing both treatment strategies.
Methods: The bibliographic databases MEDLINE, Cochrane, PubMed, EMBASE and Google Scholar were searched from inception to October 2019. Search terms included (chyle [title/abstract]) OR (chylous [title/abstract]) AND (fistula [title/abstract]) OR (fistulae [title/abstract]) OR (leak [title/abstract]) AND (neck [title/abstract]) OR (dissection [title/abstract]). The study was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Risk of bias was assessed using guidelines from the Joanna Briggs Institute. Outcome measures included the proportion of chylous fistulae that spontaneously resolved without the need for surgery and time taken until resolution, for both DM and octreotide, respectively.
Results: The primary search identified 20 articles for review, comprising 313 patients. Two studies were suitable for pooled analysis. There was no statistically significant difference in the time taken for chylous fistula to resolve between groups (octreotide 10.0 days; ODM 12.0 days; P = .38). The overall rate of resolution was 89.6% and 81.5%, respectively (P = .25). Surgery was highly effective in cases failing to resolve following intervention with either method (96% [53/55] patients).
Conclusion: The use of octreotide for chylous fistula following neck dissection surgery is associated with a high rate of spontaneous resolution. However, significant heterogeneity, bias and concurrent use of ODM/TPN for patients in studies investigating octreotide precludes universal recommendation at this time. Further research in the form of randomised controlled trials is required to establish an independent treatment effect.
Keywords: chyle; diet; neck dissection; octreotide; parental nutrition.
© 2020 John Wiley & Sons Ltd.
Similar articles
-
Effect of Octreotide in stopping post surgical chyle leak in neck Dissection-A systematic review.J Oral Biol Craniofac Res. 2022 Sep-Oct;12(5):737-741. doi: 10.1016/j.jobcr.2022.08.018. Epub 2022 Aug 20. J Oral Biol Craniofac Res. 2022. PMID: 36110865 Free PMC article. Review.
-
Conservative management of postoperative chylous fistula with octreotide and peripheral total parenteral nutrition.Ear Nose Throat J. 2017 Jul;96(7):264-267. doi: 10.1177/014556131709600720. Ear Nose Throat J. 2017. PMID: 28719710
-
Use of Octreotide for the Management of Chyle Fistula Following Neck Dissection.JAMA Otolaryngol Head Neck Surg. 2015 Aug;141(8):723-7. doi: 10.1001/jamaoto.2015.1176. JAMA Otolaryngol Head Neck Surg. 2015. PMID: 26135979
-
A prospective study on the role of octreotide in management of chyle fistula neck.Laryngoscope. 2015 Jul;125(7):1624-7. doi: 10.1002/lary.25171. Epub 2015 Jan 30. Laryngoscope. 2015. PMID: 25639346
-
Evolution of chylous fistula management after neck dissection.Curr Opin Otolaryngol Head Neck Surg. 2013 Apr;21(2):150-6. doi: 10.1097/MOO.0b013e32835e9d97. Curr Opin Otolaryngol Head Neck Surg. 2013. PMID: 23449286 Review.
Cited by
-
Chyle leak after head and neck surgeries: a comprehensive review of diagnosis and management strategies.J Korean Assoc Oral Maxillofac Surg. 2024 Feb 29;50(1):3-12. doi: 10.5125/jkaoms.2024.50.1.3. J Korean Assoc Oral Maxillofac Surg. 2024. PMID: 38419516 Free PMC article. Review.
-
Nutritional management of chyle leak after head and neck surgery: a systematic review and proposed protocol for management.Oral Maxillofac Surg. 2024 Mar;28(1):51-62. doi: 10.1007/s10006-023-01152-8. Epub 2023 Apr 4. Oral Maxillofac Surg. 2024. PMID: 37014458 Review.
-
Case report: Balloon compression for cervical chyle leakage post neck dissection.Front Surg. 2022 Sep 23;9:1019425. doi: 10.3389/fsurg.2022.1019425. eCollection 2022. Front Surg. 2022. PMID: 36211290 Free PMC article.
-
Effect of Octreotide in stopping post surgical chyle leak in neck Dissection-A systematic review.J Oral Biol Craniofac Res. 2022 Sep-Oct;12(5):737-741. doi: 10.1016/j.jobcr.2022.08.018. Epub 2022 Aug 20. J Oral Biol Craniofac Res. 2022. PMID: 36110865 Free PMC article. Review.
-
Management of chyle leaks following esophageal resection: a systematic review.Dis Esophagus. 2021 Nov 11;34(11):doab012. doi: 10.1093/dote/doab012. Dis Esophagus. 2021. PMID: 33723611 Free PMC article.
References
REFERENCES
-
- Spiro JD, Spiro RH, Strong EW. The management of chyle fistula. Laryngoscope. 1990;100(7):771-774.
-
- Roh J-L, Kim DH, Park CI. Prospective identification of chyle leakage in patients undergoing lateral neck dissection for metastatic thyroid cancer. Ann Surg Oncol. 2008;15(2):424-429.
-
- Delaney SW, Shi H, Shokrani A, Sinha UK. Management of chyle leak after head and neck surgery: review of current treatment strategies. Int J Otolaryngol. 2017;2017:1-12.
-
- Buettiker V, Hug M, Burger R, Baenziger O. Somatostatin: a new therapeutic option for the treatment of chylothorax. Intensive Care Med. 2001;27(6):1083-1086.
-
- Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the prisma statement. PLoS Medicine. 2009;6(7):e1000097.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
